Comparison between Perineural vs intravenous magnesium sulphate as an adjuvant to levobupivacaine using ultrasound

Comparison of perineural & intravenous magnesium sulphate as an adjuvant to levobupivacaine in ultrasound â?? guided supraclavicular brachial plexus block: A prospective randomized trial - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054840

Enrollment

Registered

2023-07-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intravenous magnesium sulphate: patient will receive 0.5% levobupivacaine (24.5ml) with 0.5ml NS total volume of 25ml in usg guided supraclavicular nerve block plus 30 mg/kg iv magnesiu

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 - 60 years 2.Both sexes 3. ASA Classes I,II and III patients 4. Patients posted for upper limb surgery below shoulder

Exclusion criteria

Exclusion criteria: 1.Patient refusal 2. Coagulopathy 3. History of allergy to local anesthetics 4. Infection at the site of block 5. Neurodeficit involving brachial plexus 6. Pregnant women 7. Patients with psychiatric behavior 8. ASA Class IV patients 9.Obese patients BMI >35kg/m2

Design outcomes

Primary

Measure	Time frame
To compare the onset of sensory & motor blockTimepoint: One year	—

Secondary

Measure	Time frame
â?¢To compare the duration of analgesia â?¢To compare the requirement of rescue analgesic in the postoperative period â?¢ To compare the side effects (if any)Timepoint: One year	—

Countries

India

Contacts

Public ContactDr Koushallya Sri S

Chettinad academy of research and education

dranandmurugan@gmail.com9444486183

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026